OncoDaily Announces Strategic Partnership with AIM-HI Accelerator Fund

OncoDaily is excited to announce a strategic partnership with the AIM-HI Accelerator Fund (AIM-HI). By leveraging the strengths of both organizations, this partnership aims to promote awareness, recognize outstanding achievements of entrepreneurs and early-stage oncology companies, and help accelerate the development of cutting-edge cancer therapies and technologies.

This partnership marks a pivotal step in our shared mission to advance biotech innovation and cancer research, making a meaningful impact on the global community.

About OncoDaily

OncoDaily is a premier digital platform dedicated to delivering the latest news, research developments, and insights in the field of oncology. Our goal is to empower healthcare professionals, researchers, and patients by providing accessible, high-quality information that enhances understanding and drives progress in cancer research and treatment. OncoDaily is committed to leading the charge in the fight against cancer, offering a wealth of educational content, podcasts, and expert-led discussions to inspire the global oncology community.

About AIM-HI Accelerator Fund

The AIM-HI Accelerator Fund (AIM-HI) was created in 2019 by the National Foundation for Cancer Research to provide oncology startups with the resources they need to drive innovative discoveries forward, out of the lab, to the clinics, and eventually to the people battling cancer. Our non-profit changes the paradigm of funding biotech startups, utilizing charitable giving to make impact investments. Our mission is to bridge the gap between research breakthroughs and clinical trials, with the ultimate goal of developing innovative cancer therapies and technologies that can save patients’ lives.